Armata Pharmaceuticals
(NYSEMKT) ARMP
Armata Pharmaceuticals Financials at a Glance
Market Cap
$277.53M
Revenue (TTM)
$2.96M
Net Income (TTM)
-$282.61M
EPS (TTM)
-$7.76
P/E Ratio
-0.97
Dividend
$0.00
Beta (Volatility)
0.44 (Low)
Dividend
$0.00
Beta (Volatility)
0.44 (Low)
Price
$7.43
Volume
4,633
Open
$7.34
Price
$7.43
Volume
4,633
Open
$7.34
Previous Close
$7.43
Daily Range
$7.25 - $7.99
52-Week Range
$1.74 - $16.34
Estimated Earnings Date
Aug 11, 2026
Dividend
$0.00
Beta (Volatility)
0.44 (Low)
Price
$7.43
Volume
4,633
Open
$7.34
Previous Close
$7.43
Daily Range
$7.25 - $7.99
52-Week Range
$1.74 - $16.34
Estimated Earnings Date
Aug 11, 2026
ARMP News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Armata Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
61
CEO
Deborah L. Birx, MD
Website
www.armatapharma.comHeadquarters
Marina del Rey, CA 90292, US
ARMP Financials
Key Financial Metrics (TTM)
Gross Margin
72%
Operating Margin
-13%
Net Income Margin
-96%
Return on Equity
0%
Return on Capital
-61%
Return on Assets
-4%
Earnings Yield
-1.03%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$277.53M
Shares Outstanding
36.71M
Volume
4.63K
Avg. Volume
60.49K
Financials (TTM)
Gross Profit
$3.37M
Operating Income
-$31.22M
EBITDA
-$155.68M
Operating Cash Flow
-$25.76M
Capital Expenditure
-$542.00K
Free Cash Flow
-$26.31M
Cash & ST Invst.
$8.69M
Total Debt
$288.02M
Armata Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$789.00K
+60.7%
Gross Profit
$332.00K
+191.2%
Gross Margin
42.08%
N/A
Market Cap
$277.53M
N/A
Market Cap/Employee
$4.63M
N/A
Employees
60
N/A
Net Income
-$115.35M
-1666.1%
EBITDA
-$109.33M
-4184.1%
Quarterly Fundamentals
Total Cash
$4.75M
-59.3%
Total Debt
$373.67M
+177.5%
Accounts Receivable
$47.00K
-80.3%
Inventory
$0.00
N/A
Long Term Debt
$369.08M
+1246.2%
Short Term Debt
$4.59M
-95.7%
Return on Assets
-4.05%
N/A
Return on Invested Capital
-61.46%
N/A
Free Cash Flow
-$5.85M
+23.9%
Operating Cash Flow
-$5.78M
+23.7%